News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Temporary ET break for pregnancy safe in the short term for breast cancer survivors
09 May 2023
byChristina Lau
Temporary interruption of adjuvant endocrine therapy (ET) to allow for pregnancy has demonstrated short-term safety, with no increase in risk of breast cancer events, including distant recurrence, in hormone receptor–positive breast cancer survivors who have completed 18–30 months of adjuvant ET.
09 May 2023







